VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 148 filers reported holding VIKING THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $0 | – | 40 | -77.8% | 0.00% | – |
Q3 2022 | $0 | – | 180 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 180 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 180 | 0.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 180 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 180 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 180 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 180 | -18.2% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 220 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 220 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $1,000 | 0.0% | 220 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $1,000 | 0.0% | 220 | -11.3% | 0.00% | – |
Q4 2019 | $1,000 | -97.1% | 248 | -95.3% | 0.00% | -100.0% |
Q3 2019 | $35,000 | -20.5% | 5,248 | -3.3% | 0.01% | -15.4% |
Q2 2019 | $44,000 | -22.8% | 5,428 | -6.9% | 0.01% | -35.0% |
Q1 2019 | $57,000 | +50.0% | 5,830 | +16.6% | 0.02% | +53.8% |
Q4 2018 | $38,000 | -88.8% | 5,000 | -74.4% | 0.01% | -83.5% |
Q3 2018 | $339,000 | +505.4% | 19,534 | +223.7% | 0.08% | +259.1% |
Q2 2018 | $56,000 | – | 6,035 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |